Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
299.45
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $7.64 billion as of April 28, 2026. Its market cap has increased by 20.83% in one year.
Market Cap
7.64B
Enterprise Value
7.49B
1-Year Change
20.83%
Ranking
Category
Stock Price
$299.45
Market Cap Chart
Since April 29, 2021, Bio-Rad Laboratories's market cap has decreased from $19.07B to $7.64B, a decrease of -59.93%. That is a compound annual growth rate of -16.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.75B | -5.00% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 18.59% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smith & Nephew | 13.68B |
| Insulet | 13.04B |
| Penumbra | 12.90B |
| Globus Medical | 12.71B |
| Masimo | 9.33B |
| Bio-Rad Laboratories | 7.75B |
| Glaukos | 7.14B |
| Bruker | 5.56B |